Finecure Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2005.
2005 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Finecure Pharmaceuticals Limited

Finecure Pharmaceuticals Limited, a active public limited company, was established on 18 March 2005 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2005PLC045724. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹12.71 Cr.

It upholds a compliant status. Employing 454 professional, Its leadership includes Vivek Rajgarhia (Whole-Time Director), Vishal Haremurari Rajgarhia (Whole-Time Director), Vikash Rajgarhia (Managing Director). Past directors included Vivek Rajgarhia, Vishal Haremurari Rajgarhia, Vikash Rajgarhia. It holds ₹65.19 Cr open charges and ₹26.58 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-1201, Mondeal Heights, Nr. Wide Angle, S.G. Highway,, Ahmedabad, Gujarat, 380015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2005PLC045724

  • Registration Number

    045724

  • Incorporation Date

    18 March 2005

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹12.71 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 12.71 Cr
  • Company Age 20 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 65.19 Cr
  • Satisfied Charges ₹ 26.58 Cr
  • Revenue Growth **** 8.25%
  • Profit Growth **** -30.02%
  • Ebitda **** -14.35%
  • Net Worth 5.99%
  • Total Assets **** 10.15%
Company report

Finecure Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Finecure Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Finecure Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Vivek Rajgarhia Whole-Time Director 18 Mar 2005 Current
Vishal Haremurari Rajgarhia Whole-Time Director 18 Mar 2005 Current
Vikash Rajgarhia Managing Director 18 Mar 2005 Current
Niraj Kumar Harodia Director 28 Jan 2025 Current
Anshu Krishnakumar Agrawal Director 21 Dec 2017 Current
Mukesh Tarachand Agarwal Director 21 Dec 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2010 Past
Pramod Abcsdd Director 21 Dec 2017 Past
Pramod Abcsdd Director 21 Dec 2017 Past
Pramod Abcsdd Director 05 Feb 2018 Past
Pramod Abcsdd Director 01 Nov 2024 Past
Pramod Abcsdd Director 08 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Finecure Pharmaceuticals.

Finecure Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.25% increase. The company also saw a substantial fall in profitability, with a 30.02% decrease in profit. The company's net worth moved up by a moderate rise of 5.99%.

Finecure Pharmaceuticals revenue growth over time
Finecure Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8.25%
*******
*******
*******
*******
Revenue from Operations
*******
 8.35%
*******
*******
*******
*******
Total Assets
*******
 10.15%
*******
*******
*******
*******
Profit or Loss
*******
 -30.02%
*******
*******
*******
*******
Net Worth
*******
 5.99%
*******
*******
*******
*******
EBITDA
*******
 -14.35%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Finecure Pharmaceuticals?

In 2024, Finecure Pharmaceuticals had a promoter holding of 96.85% and a public holding of 3.15%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹651,947,664.00

Satisfied Charges

₹265,821,859.00

Charges Breakdown by Lending Institutions
  • Standard Chartered Bank : 35.00 Cr
  • Sidbi : 24.21 Cr
  • Others : 5.99 Cr
Latest Charge Details
Date Lender Amount Status
06 Sep 2023 Others ₹5.90 Cr Open
24 Mar 2023 Sidbi ₹1.89 Cr Open
04 Mar 2020 Sidbi ₹22.32 Cr Open
23 Jul 2019 Standard Chartered Bank ₹35.00 Cr Open
10 Jun 2014 Others ₹0.88 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Finecure Pharmaceuticals?

Finecure Pharmaceuticals has a workforce of 454 employees as of Mar 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Finecure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finecure Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Finecure Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 12 Jan 2023 via Charge ID 100672344 with State Bank Of India was fully satisfied on 04 Dec 2025. was documented.

  • Annual General Meeting

    Finecure Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge with Sidbi of Rs. 22.32 Cr registered on 04 Mar 2020 with Charge ID 100332311 was modified on 26 May 2025. was documented.

  • Balance Sheet

    Finecure Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Progress on Niraj Kumar Harodia was appointed as a Director was appointed as a Director on 28 Jan 2025 & has been associated with this company since 1 year 1 month . was documented.

  • Charges

    Progress on A charge registered on 25 Mar 2022 via Charge ID 100561303 with Bank Of India was fully satisfied on 27 Nov 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Finecure Pharmaceuticals Limited?

The CIN of Finecure Pharmaceuticals Limited is U24230GJ2005PLC045724.

Where is Finecure Pharmaceuticals Limited headquartered?

Finecure Pharmaceuticals Limited is headquartered at A-1201, Mondeal Heights, Nr. Wide Angle, S.G. Highway,, Ahmedabad, Gujarat, 380015.

When was Finecure Pharmaceuticals Limited incorporated?

Finecure Pharmaceuticals Limited was incorporated on 18 March 2005.

Who are the current directors of Finecure Pharmaceuticals Limited?

The current directors of Finecure Pharmaceuticals Limited are

What is the primary industry of Finecure Pharmaceuticals Limited?

The primary industry of Finecure Pharmaceuticals Limited is Manufacturing.

Is Finecure Pharmaceuticals Limited a listed company?

Finecure Pharmaceuticals Limited is unlisted.

What is the capital structure of Finecure Pharmaceuticals Limited?

The authorized capital of Finecure Pharmaceuticals Limited is ₹20.00 Cr, and the paid-up capital is ₹12.71 Cr.

What is the compliance status of Finecure Pharmaceuticals Limited?

The compliance status of Finecure Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available